Precision Immunotherapy™
News & Resources

Email Alerts

Email Address *
Mailing Lists *

Enter the code shown above.


Photo Gallery


Opexa Presentation at Vatican
Regenerative Medicine Conference
MS Overview Closing bell ceremony to Nasdaq



Tcelna Process and
Mechanism of Action



Other Media Links

BioTuesdays: Opexa is Personalizing the Treatment of Autoimmune Disease

Neurology Reviews:Regulation May Be Impaired in Patients with Secondary Progressive MS

Radio Interview:OneMedRadio interviews Neil Warma, President and CEO of Opexa Therapeutics

New York Financial Press:Opexa Therapeutics - Neil Warma

First Quarter Earnings Call - 2013

FOX News: "New Therapy Could Battle Autoimmune Diseases"